|
Information For:
|
Revision BulletinHeparin Sodium and Heparin Calcium Monographs
Due to the prevalence of contaminated heparin products, USP has revised its monographs for Heparin Sodium and Heparin Calcium. These "Stage 1" revisions to the monographs are accompanied by two new and two existing USP Reference Standards (see the Heparin Hot Topics page for complete information). USP will continue efforts to revise these two heparin drug substance and related drug product monographs in future, Stage 2 revisions. Stage 2 revisions include consideration of new methodologies for identification, the development of a new potency assay and tests for impurities. Should you have any questions, please contact Anita Szajek at (301–816–8325 or . Stage 1 Heparin Monograph Revisions
What's NewChanges to the Dissolution Performance Verification Test (11/20/09) PF 35(6) Errata (10/30/09) New official Text for October: 15 Revisions Bulletins (10/30/09) Pending Standards for the month of October (10/30/09) PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09) Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09) Elemental Impurities Hot Topics information updated (10/13/09) General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09) Heparin Hot Topics information updated (10/02/09)
Related Resources |
||||||||||||||||||||||||||||
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||